March 22, 2018 / 6:22 AM / 4 months ago

BRIEF-Heidelberg Pharma FY Net Loss At EUR 11.0 Million

March 22 (Reuters) - HEIDELBERG PHARMA AG:

* FY FINANCIALS IN LINE WITH GUIDANCE ON BACK OF POSITIVE REVENUE PERFORMANCE

* FY SALES REVENUE OF EUR 1.9 MILLION (PREVIOUS YEAR: EUR 1.3 MILLION

* FY OPERATING RESULT WAS EUR -10.8 MILLION IN 2017 FISCAL YEAR (PREVIOUS YEAR: EUR -6.4 MILLION)

* FY NET LOSS FOR YEAR WAS EUR 11.0 MILLION (PREVIOUS YEAR: EUR 6.4 MILLION)

* OUTLOOK 2018: EXPECTS TO GENERATE BETWEEN EUR 3.0 MILLION AND EUR 5.0 MILLION IN SALES REVENUE AND OTHER INCOME

* OUTLOOK 2018: EBIT PROJECTED TO BE BETWEEN EUR -12.0 MILLION AND EUR -16.0 MILLION

* OUTLOOK 2018: EXPECTS TO REQUIRE FUNDS OF EUR 13.0 MILLION TO EUR 17.0 MILLION Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below